Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 657.80

+1.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (371)	1/6/2000 9:09:00 PM
From: Miljenko Zuanic	Read Replies (1) of 3557

Isn't this promotion indication that they are moving forward or that cytokine partner is closing in? Did you miss this: <<..an antagonist for vascular endothelial growth factor (VEGF) for cancer, and second generation AXOKINE® ciliary neurotrophic factor for obesity.>> Sec. gen. Axokine? Is this reason that P&G give up right on Axokine so quickly? Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next